Terms: = Thyroid cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
21 results:
1. Identification of Diagnostic Metabolic Signatures in thyroid Tumors Using Mass Spectrometry Imaging.
Mao X; Huang L; Li T; Abliz Z; He J; Chen J
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570761
[TBL] [Abstract] [Full Text] [Related]
2. Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated thyroid cancer: Global Noninterventional Study (RIFTOS MKI).
Brose MS; Smit JWA; Lin CC; Tori M; Bowles DW; Worden F; Shen DH; Huang SM; Tsai HJ; Alevizaki M; Peeters RP; Takahashi S; Rumyantsev P; Guan R; Babajanyan S; Ozgurdal K; Sugitani I; Pitoia F; Lamartina L
Thyroid; 2022 Sep; 32(9):1059-1068. PubMed ID: 35950621
[No Abstract] [Full Text] [Related]
3. NOD1 activation promotes cell apoptosis in papillary thyroid cancer.
Bai N; Liu C; Zhang X; Cheng Y; Hou D
Pathol Res Pract; 2022 May; 233():153880. PubMed ID: 35430507
[TBL] [Abstract] [Full Text] [Related]
4. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
[TBL] [Abstract] [Full Text] [Related]
5. In-Depth Proteomics Analysis to Identify Biomarkers of Papillary thyroid cancer Patients Older Than 45 Years with Different Degrees of Lymph Node Metastases.
Zhan S; Wang T; Wang M; Li J; Ge W
Proteomics Clin Appl; 2019 Sep; 13(5):e1900030. PubMed ID: 31148369
[TBL] [Abstract] [Full Text] [Related]
6. Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma.
Shen L; Qian C; Cao H; Wang Z; Luo T; Liang C
World J Surg Oncol; 2018 Dec; 16(1):235. PubMed ID: 30558624
[TBL] [Abstract] [Full Text] [Related]
7. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study.
Wei JL; Zhang JX; Fu DY
World J Surg Oncol; 2018 Dec; 16(1):236. PubMed ID: 30558615
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary thyroid Carcinoma.
Song YS; Won JK; Yoo SK; Jung KC; Kim MJ; Kim SJ; Cho SW; Lee KE; Yi KH; Seo JS; Park YJ
Thyroid; 2018 Nov; 28(11):1468-1478. PubMed ID: 30226444
[TBL] [Abstract] [Full Text] [Related]
9. Identification of Two Distinct Molecular Subtypes of Non-Invasive Follicular Neoplasm with Papillary-Like Nuclear Features by Digital RNA Counting.
Giannini R; Ugolini C; Poma AM; Urpì M; Niccoli C; Elisei R; Chiarugi M; Vitti P; Miccoli P; Basolo F
Thyroid; 2017 Oct; 27(10):1267-1276. PubMed ID: 28679352
[TBL] [Abstract] [Full Text] [Related]
10. Single nucleotide polymorphisms of the fas gene are associated with papillary thyroid cancer.
Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
[TBL] [Abstract] [Full Text] [Related]
11. Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant.
Ganly I; Wang L; Tuttle RM; Katabi N; Ceballos GA; Harach HR; Ghossein R
Hum Pathol; 2015 May; 46(5):657-64. PubMed ID: 25721865
[TBL] [Abstract] [Full Text] [Related]
12. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
[TBL] [Abstract] [Full Text] [Related]
13. The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma.
Jikuzono T; Kawamoto M; Yoshitake H; Kikuchi K; Akasu H; Ishikawa H; Hirokawa M; Miyauchi A; Tsuchiya S; Shimizu K; Takizawa T
Int J Oncol; 2013 Jun; 42(6):1858-68. PubMed ID: 23563786
[TBL] [Abstract] [Full Text] [Related]
14. Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis.
Lang BH; Wong KP; Cheung CY; Wan KY; Lo CY
Ann Surg Oncol; 2013 Apr; 20(4):1329-35. PubMed ID: 23104708
[TBL] [Abstract] [Full Text] [Related]
15. Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.
Capper D; Berghoff AS; Magerle M; Ilhan A; Wöhrer A; Hackl M; Pichler J; Pusch S; Meyer J; Habel A; Petzelbauer P; Birner P; von Deimling A; Preusser M
Acta Neuropathol; 2012 Feb; 123(2):223-33. PubMed ID: 22012135
[TBL] [Abstract] [Full Text] [Related]
16. Pathogenesis of lung cancer signalling pathways: roadmap for therapies.
Brambilla E; Gazdar A
Eur Respir J; 2009 Jun; 33(6):1485-97. PubMed ID: 19483050
[TBL] [Abstract] [Full Text] [Related]
17. fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
Mitsiades CS; Poulaki V; Fanourakis G; Sozopoulos E; McMillin D; Wen Z; Voutsinas G; Tseleni-Balafouta S; Mitsiades N
Clin Cancer Res; 2006 Jun; 12(12):3705-12. PubMed ID: 16778096
[TBL] [Abstract] [Full Text] [Related]
18. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.
Weber F; Shen L; Aldred MA; Morrison CD; Frilling A; Saji M; Schuppert F; Broelsch CE; Ringel MD; Eng C
J Clin Endocrinol Metab; 2005 May; 90(5):2512-21. PubMed ID: 15713710
[TBL] [Abstract] [Full Text] [Related]
19. Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinoma.
Kim R; Tanabe K; Uchida Y; Emi M; Toge T
Int J Mol Med; 2003 Jun; 11(6):799-804. PubMed ID: 12736725
[TBL] [Abstract] [Full Text] [Related]
20. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
Sheils OM; O'Leary JJ; Sweeney EC
J Pathol; 2000 Sep; 192(1):32-6. PubMed ID: 10951397
[TBL] [Abstract] [Full Text] [Related]
[Next]